Chronic Kidney Disease Market Share, Rising Exponentially in the Forecast Period of 2032

Comments · 153 Views

The main market drivers are an increase in kidney disease prevalence, an increase in the number of biopsy procedures, and growing demand for new techniques in the diagnosis of chronic illnesses.

Market Dynamics

In 2022, The chronic kidney disease market share was estimated to be worth USD 65.88 billion. The chronic kidney disease market is expected to increase from USD 69.44 billion in 2023 to USD 101.2 billion by 2030, with a compound annual growth rate (CAGR) of 5.5% during the forecast period (2023- 2030).

The main market drivers are an increase in kidney disease prevalence, an increase in the number of biopsy procedures, and growing demand for new techniques in the diagnosis of chronic illnesses. The number of patients with kidney failure is growing, and the advent of advanced drugs, technologies, including low maintenance dialysis equipment and artificial kidneys.

For patients with chronic illness, home dialysis is more comfortable and simpler. In addition, only a small number of donors are required in relation to the dialysis machines, so patients aren't forced to rely on them. Most patients in low- and middle-income countries do not choose to receive dialysis treatment as opposed to receiving a transplant. It is predicted that several hospital awareness campaigns will increase the number of patients testing for kidney failure. Due to an increase in the population with chronic kidney disease, people would likely increase their demand for peritoneal dialysis or haemodialysis. as a result, dialysis benefits are expected to drive the market growth. Diagnostic tests for different kidney disorders assist the market development, which is another reason why they are more readily available. In addition to growth over the forecast period, the rising number of market participants is expected to boost the market. Furthermore, they are incorporating scientific advances in order to diagnose the disease faster. Additionally, there is a growing need for diabetes and cardiovascular disease conditions to add to the goods' market over the next few years. In this way, a significant number of chronic kidney diseases would spur on the growth of the demand for the products, which promotes the growth of the market. Even, as a result of the Covid-19 pandemic, demand for home dialysis has risen worldwide. 

Segmental Analysis

The global chronic kidney disease market is segmented based on diagnosis, indication, treatment, and end-user.

It is segmented into imaging test, blood test, urine test, and kidney biopsy based on diagnosis.

Based on treatment, it is segmented into dialysis, drugs, and kidney transplant. 

Based on indication, it is segmented into Type 1 or Type 2 diabetes, polycystic kidney disease, high blood pressure, and others.

Based on end-user, it is segmented into diagnostic centers, hospitals and clinics, and others.

Regional Analysis

an increase in population drives the American kidney disease market and new test capabilities are factors for detecting kidney failure. therefore the USA is projected to be the world's largest kidney disease market inisghts because of the rise in the prevalence of Chronic Conditions and the improvement in healthcare.

kidney disease awareness is rising the popularity of the medical device industry in Europe Additionally, the rapidly growing diabetic population along with substantial investment in medical devices fuels the increasing business growth of the market. Germany, the largest market for long-term kidney disease, is spurred by growth in part by increased investment in R&D, increased R&D funding, and new investment.

Asia Pacific is a rising market for chronic kidney disease due to diabetes and cardiovascular disease prevalence. Improving the hospital infrastructure, a specialist healthcare workforce, and improved technologies are also expected to increase market growth over the next few years. This is partly due to increased healthcare spending, technologically advanced devices, government information about CKD, and the construction of state-of-the-art medical-art centers in the city.

Another contributing factor to the lower kidney disease incidence in these regions is that the Middle East and Africa have the least access to technology and aren't well aware of the treatment options.

Competitive Analysis

Some of the eminent players in the market are Abbott, Siemens, Sysmex, Beckman Coulter, F. Hoffmann-La Roche Ltd, ACON Laboratories, Inc., URIT Medical, Nova Biomedical, ARKRAY, OPTI Medical, 77 Elektronika, Randox Laboratories, Teva Pharmaceutical Industries Ltd., Amgen Inc., AstraZeneca Plc, Pfizer Inc., F. Hoffmann-La Roche Ltd., Sanofi S.A., GlaxoSmithKline Plc, AbbVie Inc., and Kissei Pharmaceutical Co. Ltd. The launch of new products and add-ons and business strategies to the existing product portfolios are the most important long-term trends in the industry. Advanced technical products are being introduced to the market by a few main players in order to give them a leading edge.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: [email protected]

Website: https://www.marketresearchfuture.com

Comments